Page 86 - Avian Virology: Current Research and Future Trends

Newcastle Disease Virus | 79
of lentogenic, mesogenic, and velogenic Newcastle Disease virus Pantua, H.D., McGinnes, L.W., Peeples, M.E., and Morrison, T.G. (2006).
strains in day-old chickens. Vet. Pathol. 53, 53–64. https://doi. Requirements for the assembly and release of Newcastle disease
org/10.1177/0300985815600504 virus-like particles. J. Virol. 80, 11062–11073.
Murulitharan, K., Yusoff, K., Omar, A.R., and Molouki, A. (2013). Park, M.S., Shaw, M.L., Muñoz-Jordan, J., Cros, J.F., Nakaya, T., Bouvier, N.,
Characterization of Malaysian velogenic NDV strain AF2240-I genomic Palese, P., García-Sastre, A., and Basler, C.F. (2003). Newcastle disease
sequence: a comparative study. Virus Genes 46, 431–440. https://doi. virus (NDV)-based assay demonstrates interferon-antagonist activity for
org/10.1007/s11262-012-0874-y the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77,
Nagai, Y., Klenk, H.D., and Rott, R. (1976). Proteolytic cleavage of the viral 1501–1511.
glycoproteins and its significance for the virulence of Newcastle disease Park, M.S., Steel, J., García-Sastre, A., Swayne, D., and Palese, P. (2006).
virus. Virology 72, 494–508. Engineered viral vaccine constructs with dual specificity: avian influenza
Nakaya, T., Cros, J., Park, M.S., Nakaya, Y., Zheng, H., Sagrera, A., Villar, and Newcastle disease. Proc. Natl. Acad. Sci. U.S.A. 103, 8203–8208.
E., García-Sastre, A., and Palese, P. (2001). Recombinant Newcastle Parry, S., and Aitken, I. (1977). Local immunity in the respiratory tract of the
disease virus as a vaccine vector. J. Virol. 75, 11868–11873. https://doi. chicken. II The secretory immune response to Newcastle disease virus
org/10.1128/JVI.75.23.11868-11873.2001 and the role of IgA. Vet. Microbiol. 2, 143–165.
Nayak, B., Rout, S.N., Kumar, S., Khalil, M.S., Fouda, M.M., Ahmed, Pearson, J.E., Senne, D.A., Alexander, D.J., Taylor, W.D., Peterson, L.A., and
L.E., Earhart, K.C., Perez, D.R., Collins, P.L., and Samal, S.K. (2009). Russell, P.H. (1987). Characterization of Newcastle disease virus (avian
Immunization of chickens with Newcastle disease virus expressing H5 paramyxovirus-1) isolated from pigeons. Avian Dis. 31, 105–111.
hemagglutinin protects against highly pathogenic H5N1 avian influenza Pedersen, J.C., Senne, D.A., Woolcock, P.R., Kinde, H., King, D.J., Wise,
viruses. PLOS ONE 4, e6509. https://doi.org/10.1371/journal. M.G., Panigrahy, B., and Seal, B.S. (2004). Phylogenetic relationships
pone.0006509 among virulent Newcastle disease virus isolates from the 2002-2003
Nishio, M., Ohtsuka, J., Tsurudome, M., Nosaka, T., and Kolakofsky, D. outbreak in California and other recent outbreaks in North America. J.
(2008). Human parainfluenza virus type 2 V protein inhibits genome Clin. Microbiol. 42, 2329–2334.
replication by binding to the L protein: possible role in promoting viral Peeples, M.E. (1988). Differential detergent treatment allows
fitness. J. Virol. 82, 6130–6138. https://doi.org/10.1128/JVI.02635-07 immunofluorescent localization of the Newcastle disease virus matrix
Ochi, Y., and Hashimoto, K. (1929). Uber eine neue Geflugelseuche in protein within the nucleus of infected cells. Virology 162, 255–259.
Korea, 6th Rept. Govt. Inst. Vet. Res. (Chosen), 16. Peeters, B.P., de Leeuw, O.S., Koch, G., and Gielkens, A.L. (1999). Rescue
Ogino, T., and Banerjee, A.K. (2007). Unconventional mechanism of of Newcastle disease virus from cloned cDNA: evidence that cleavability
mRNA capping by the RNA-dependent RNA polymerase of vesicular of the fusion protein is a major determinant for virulence. J. Virol. 73,
stomatitis virus. Mol. Cell 25, 85–97. 5001–5009.
Oh, S.W., Onomoto, K., Wakimoto, M., Onoguchi, K., Ishidate, F., Fujiwara, Pegg, C.L., Hoogland, C., and Gorman, J.J. (2017). Site-specific glycosylation
T., Yoneyama, M., Kato, H., and Fujita, T. (2016). Leader-containing of the Newcastle disease virus haemagglutinin-neuraminidase. Glycoconj.
uncapped viral transcript activates RIG-I in antiviral stress granules. J. 34, 181–197. https://doi.org/10.1007/s10719-016-9750-7
PLOS Pathog. 12, e1005444. https://doi.org/10.1371/journal. Perozo, F., Merino, R., Afonso, C.L., Villegas, P., and Calderon, N. (2008).
ppat.1005444 Biological and phylogenetic characterization of virulent Newcastle
OIE, 2012. Newcastle disease, Biological Standards Commission, Manual disease virus circulating in Mexico. Avian Dis. 52, 472–479. https://doi.
of diagnostic tests and vaccines for terrestrial animals: mammals, birds org/10.1637/8276-022908-Reg.1
and bees, 7th ed. World Organization for Animal Health, Paris, France, Pitt, J.J., Da Silva, E., and Gorman, J.J. (2000). Determination of the
pp.555–574. disulfide bond arrangement of Newcastle disease virus hemagglutinin
Paldurai, A., Kumar, S., Nayak, B., and Samal, S.K. (2010). Complete neuraminidase. Correlation with a beta-sheet propeller structural fold
genome sequence of highly virulent neurotropic Newcastle disease virus predicted for paramyxoviridae attachment proteins. J. Biol. Chem. 275,
strain Texas GB. Virus Genes 41, 67–72. https://doi.org/10.1007/ 6469–6478.
s11262-010-0486-3 Poch, O., Blumberg, B.M., Bougueleret, L., and Tordo, N. (1990).
Paldurai, A., Xiao, S., Kim, S.H., Kumar, S., Nayak, B., Samal, S., Collins, Sequence comparison of five polymerases (L proteins) of
P.L., and Samal, S.K. (2014a). Effects of naturally occurring six- and unsegmented negative-strand RNA viruses: theoretical assignment
twelve-nucleotide inserts on Newcastle disease virus replication and of functional domains. J. Gen. Virol. 71, 1153–1162. https://doi.
pathogenesis. PLOS ONE 9, e103951. https://doi.org/10.1371/ org/10.1099/0022-1317-71-5-1153
journal.pone.0103951 Pomeroy, L.W., Bjørnstad, O.N., and Holmes, E.C. (2008). The evolutionary
Paldurai, A., Kim, S.H., Nayak, B., Xiao, S., Shive, H., Collins, P.L., and and epidemiological dynamics of the paramyxoviridae. J. Mol. Evol. 66,
Samal, S.K. (2014b). Evaluation of the contributions of individual viral 98–106. https://doi.org/10.1007/s00239-007-9040-x
genes to Newcastle disease virus virulence and pathogenesis. J. Virol. 88, Porotto, M., Fornabaio, M., Greengard, O., Murrell, M.T., Kellogg, G.E.,
8579–8596. https://doi.org/10.1128/JVI.00666-14 and Moscona, A. (2006). Paramyxovirus receptor-binding molecules:
Palya, V., Kiss, I., Tatár-Kis, T., Mató, T., Felföldi, B., and Gardin, Y. (2012). engagement of one site on the hemagglutinin-neuraminidase protein
Advancement in vaccination against Newcastle disease: recombinant modulates activity at the second site. J. Virol. 80, 1204–1213.
HVT NDV provides high clinical protection and reduces challenge virus Porotto, M., Salah, Z., DeVito, I., Talekar, A., Palmer, S.G., Xu, R., Wilson, I.A.,
shedding with the absence of vaccine reactions. Avian Dis. 56, 282–287. and Moscona, A. (2012). The second receptor binding site of the globular
https://doi.org/10.1637/9935-091511-Reg.1 head of the Newcastle disease virus hemagglutinin-neuraminidase
Panda, A., Huang, Z., Elankumaran, S., Rockemann, D.D., and Samal, S.K. activates the stalk of multiple paramyxovirus receptor binding proteins
(2004a). Role of fusion protein cleavage site in the virulence of Newcastle to trigger fusion. J. Virol. 86, 5730–5741. https://doi.org/10.1128/
disease virus. Microb. Pathog. 36, 1–10. JVI.06793-11
Panda, A., Elankumaran, S., Krishnamurthy, S., Huang, Z., and Powell, J.R., Aitken, I.D., and Survashe, B.D. (1979). The response of the
Samal, S.K. (2004b). Loss of N-linked glycosylation from the Harderian gland of the fowl to antigen given by the ocular route. II.
hemagglutinin-neuraminidase protein alters virulence of Newcastle Antibody production. Avian Pathol. 8, 363–373.
disease virus. J. Virol. 78, 4965–4975. Pühler, F., Willuda, J., Puhlmann, J., Mumberg, D., Römer-Oberdörfer, A.,
Panigrahy, B., Senne, D.A., Pearson, J.E., Mixson, M.A., and Cassidy, D.R. and Beier, R. (2008). Generation of a recombinant oncolytic Newcastle
(1993). Occurrence of velogenic viscerotropic Newcastle disease in pet disease virus and expression of a full IgG antibody from two transgenes.
and exotic birds in 1991. Avian Dis. 37, 254–258. Gene Ther. 15, 371–383. https://doi.org/10.1038/sj.gt.3303095
Pantua, H., McGinnes, L.W., Leszyk, J., and Morrison, T.G. (2005). Puhlmann, J., Puehler, F., Mumberg, D., Boukamp, P., and Beier, R. (2010).
Characterization of an alternate form of Newcastle disease virus fusion Rac1 is required for oncolytic NDV replication in human cancer
protein. J. Virol. 79, 11660–11670. cells and establishes a link between tumorigenesis and sensitivity to
oncolytic virus. Oncogene 29, 2205–2216. https://doi.org/10.1038/
onc.2009.507